Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04846127 · ClinicalTrials.gov registry record

CanGaroo® Registry Study

A clinical trial of Arrhythmias, Cardiac, sponsored by Elutia.

Completed
Registry status
500
Enrollment target
20
Study locations

NCT04846127 is a study of Arrhythmias, Cardiac that has completed, run by Elutia. The registered enrollment target is 500 participants, roughly in line with the 533-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target. The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04846127, a study of Arrhythmias, Cardiac, has completed, sponsored by Elutia.

COMPLETED
Registry status
500 participants
Enrollment target
20
Study locations

Study Summary

A Multi-Center Registry Evaluating Participants Who Receive CanGaroo Envelope or No Envelope During their CIED Implantation

Conditions Studied

Interventions

  • DEVICE CanGaroo Envelope

Study Locations (20)

Florida

  • Daytona Heart Group - Daytona Beach
  • The Arrhythmia Center of South Florida - Delray Beach
  • Florida Heart Rhythm Specialists, PLLC - Fort Lauderdale
  • VA Medical Center - Gainesville
  • Cardiovascular Associates/Osceola Regional Medical Center - Kissimmee
  • Advent Health - Tampa

Michigan

  • Sparrow Clinical Research Institute - Lansing
  • Ascension Providence Hospital - Southfield
  • Metro Health/University of Michigan Health - Wyoming

North Carolina

  • UNC Health/NC Heart & Vascular Research - Raleigh
  • New Hanover Regional Medical Center - Wilmington

Arkansas

  • Arkansas Heart Hospital - Little Rock

Indiana

  • Baptist Health Floyd - New Albany

Kentucky

  • St. Joseph Hospital - Lexington

Maine

  • Eastern Maine Medical Center - Bangor

Massachusetts

  • Brigham & Women's Hospital, Cardiovascular Division - Boston

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-05-25
Est. Completion 2024-10-17

Sponsor

Elutia

10 total trials

What the Registry Record Tells You About NCT04846127

The ClinicalTrials.gov registry entry for NCT04846127 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 533-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target. The listed sponsor is Elutia, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arrhythmias, Cardiac appearing as the primary indexed condition, and to 1 intervention - of which CanGaroo Envelope is the first listed.

NCT04846127 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Michigan, North Carolina.

Frequently Asked Questions

What is clinical trial NCT04846127 about?

NCT04846127 is a clinical study titled "CanGaroo® Registry Study". A Multi-Center Registry Evaluating Participants Who Receive CanGaroo Envelope or No Envelope During their CIED Implantation

What is the current status of trial NCT04846127?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2021-05-25. Estimated completion is 2024-10-17.

What conditions does trial NCT04846127 study?

This clinical trial studies the following conditions: Arrhythmias, Cardiac.

What interventions are being tested in trial NCT04846127?

The interventions under investigation include: CanGaroo Envelope (DEVICE).

Who is sponsoring clinical trial NCT04846127?

This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04846127 being conducted?

This trial has 20 study locations across Arkansas, Florida, Indiana, Kentucky, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arrhythmias, Cardiac

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.